Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.6.2905

Incidence and Clinical Outcomes of Non-endometrioid Carcinoma of Endometrium: Siriraj Hospital Experience  

Jaishuen, Atthapon (Department of Obstetrics and Gynaecology, Faculty of Medicine, Siriraj Hospital, Mahidol University)
Kunakornporamat, Kate (Department of Obstetrics and Gynaecology, Faculty of Medicine, Siriraj Hospital, Mahidol University)
Viriyapak, Boonlert (Department of Obstetrics and Gynaecology, Faculty of Medicine, Siriraj Hospital, Mahidol University)
Benjapibal, Mongkol (Department of Obstetrics and Gynaecology, Faculty of Medicine, Siriraj Hospital, Mahidol University)
Chaopotong, Pattama (Department of Obstetrics and Gynaecology, Faculty of Medicine, Siriraj Hospital, Mahidol University)
Petsuksiri, Janjira (Department of Radiology, Faculty of Medicine, Siriraj Hospital, Mahidol University)
Therasakvichya, Suwanit (Department of Obstetrics and Gynaecology, Faculty of Medicine, Siriraj Hospital, Mahidol University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.6, 2014 , pp. 2905-2909 More about this Journal
Abstract
Background: To study the incidence of non-endometrioid carcinoma of endometrium and compare the clinical characteristics and treatment outcomes with endometrioid carcinoma patients. Materials and Methods: This study included 236 patients with endometrial carcinoma at Siriraj Hospital whom were diagnosed and treated from 2003 through 2006. The clinical characteristics, pathological features, treatment and clinical outcomes were collected from the medical records. The 5-year survival was calculated according to 2009 FIGO staging. Results: Non-endometrioid carcinoma of endometrium accounted for 10.2% of all endometrial carcinomas (24/236 patients). The 5-year survival rate was significantly lower in the non-endometrioid group compared to the endometrioid group (77.3% vs 96%, p<0.001) and clinical data pointed to greater malignancy. Conclusions: Non-endometrioid carcinoma of endometrium is relative rare but is more aggressive, has more distant metastasis at diagnosis with a worse survival rate than endometrioid carcinoma. Only patients in stage IA with no residual disease on a hysterectomy specimen may not need adjuvant treatment.
Keywords
Endometrial carcinoma; non-endometrioid; survival outcome; distant metastasis;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009). Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet, 373, 125-36.   DOI   ScienceOn
2 Olawaiye AB, Boruta DM (2009). Management of women with clear cell endometrial cancer A Society of Gynecologic Oncology (SGO) review. Gynecologic Oncology, 113, 277-83.   DOI   ScienceOn
3 Siegel R, Naishadham D and Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30.   DOI   ScienceOn
4 Slomovitz BM, Burke TW, Eifel PJ, et al (2003). Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol Oncol, 91, 463-9.   DOI   ScienceOn
5 Todo Y, Kato H, Kaneuchi M, et al (2010). Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet, 376, 1165-72.
6 Wilairat W, Benjapibal M (2012). Presence of anemia and poor prognostic factors in patients with endometrial carcinoma. Asian Pac J Cancer Prev, 13, 3187-90.   DOI   ScienceOn
7 Wilson TO, Podratz KC, Gaffey TA, et al (1990). Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma. Am J Obstet Gynecol, 162, 418-23.   DOI   ScienceOn
8 Desai NB, Kiess AP, Kollmeier MA, et al (2013). Patterns of relapse in stage I-II uterine papillary serous carcinoma treated with adjuvant intravaginal radiation (IVRT) with or without chemotherapy. Gynecol Oncol, 131, 604-8.   DOI   ScienceOn
9 Fader AN, Boruta D, Olawaiye AB, Gehrig PA (2010). Uterine papillary serous carcinoma: epidemiology, pathogenesis and management. Curr Opin Obstet Gynecol, 22, 21-9.   DOI
10 Ferlay J, Shin HR, Bray F, et al (2008). "GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer.
11 Hamilton CA, Cheung MK, Osann K, et al (2006). Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br J Cancer, 94, 642-6.
12 Jhingran A, Ramondetta LM, Bodurka DC, et al (2013). A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium. Gynecol Oncol, 129, 304-9.   DOI   ScienceOn
13 Kelly MG, O'Malley D M, Hui P, et al (2005). Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. Gynecol Oncol, 98, 353-9.   DOI   ScienceOn
14 Khunhaprema T, Attasara P, Sriplung H, et al (2012). Cancer in Thailand. Volume VI, 2004-2006. Bangkok, National Cancer Institute, Department od Medical Service, Ministry of Public Health.
15 Kim HJ, Kim TJ, Lee YY, et al (2013). A comparison of uterine papillary serous, clear cell carcinomas, and grade 3 endometrioid corpus cancers using 2009 FIGO staging system. J Gynecol Oncol, 24, 120-7.   DOI   ScienceOn
16 Barney BM, Petersen IA, Mariani A, et al (2013). The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer. Int J Radiat Oncol Biol Phys, 85, 109-15.   DOI   ScienceOn
17 Benedetti Panici P, Basile S, Maneschi F, et al (2008). Systematic pelvic lymphadenectomy vs. no lymphadenectomy in earlystage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst, 100, 1707-16.   DOI   ScienceOn
18 Chan JK, Cheung MK, Huh WK, et al (2006). Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer, 107, 1823-30.   DOI   ScienceOn
19 Bjorge T, Engeland A, Tretli S, Weiderpass E (2007). Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. Int J Cancer, 120, 378-83.   DOI   ScienceOn
20 Boruta DM, Gehrig PA, Fader AN, Olawaiye AB (2009). Management of women with uterine papillary serous cancer: A Society of Gynecologic Oncology (SGO) review. Gynecologic Oncol, 115, 142-53.   DOI   ScienceOn
21 Chang-Halpenny CN, Natarajan S, Hwang-Graziano J (2013). Early stage papillary serous or clear cell carcinoma confined to or involving an endometrial polyp: outcomes with and without adjuvant therapy. Gynecol Oncol, 131, 598-603.   DOI   ScienceOn
22 Creasman WT, Odicino F, Maisonneuve P, et al (2006). Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet, 95, 105-43.   DOI   ScienceOn
23 Gehrig PA, Van Le L, Fowler WC Jr (2003). The role of omentectomy during the surgical staging of uterine serous carcinoma. Int J Gynecol Cancer, 13, 212-5.